Skip to main content
. 2024 Oct 14;21:182. doi: 10.1186/s12954-024-01097-5

Table 1.

Participants characteristics by xylazine awareness among people who use drugs — Ohio, 2023–2024

Characteristic Overall Xylazine awareness a
Yes No P-valueb PR c (95% CI)
No. (%) No. (%) No. (%)
Total 630 (100.0) 293 (46.5) 337 (53.5)
Age, yrs
Mean (std dev) 43.0 (11.2) 40.7 (10.1) 45.0 (11.7) < 0.0001 0.99 (0.98–0.99)
Median (range) 42 (19–77) 40 (19–74) 45 (19–77)
Sex
Female 249 (39.6) 122 (41.8) 127 (37.7) 0.3247 Ref
Male 372 (59.1) 168 (57.5) 204 (60.5) 0.98 (0.83–1.16)
Other d 8 (1.3) 2 (0.7) 6 (1.8) 0.62 (0.20–1.98)
Missing e 1 1 0
Race
Black or African American 152 (24.5) 46 (15.9) 106 (31.9) < 0.0001 0.70 (0.54–0.91)
White, European American, or Middle Eastern 404 (65.1) 213 (73.7) 191 (57.5) Ref
Other f 65 (10.5) 30 (10.4) 35 (10.5) 0.89 (0.67–1.16)
Missing e 9 4 5
Ethnicity
Hispanic or Latino 28 (4.5) 14 (4.8) 14 (4.2) 0.7167
Not Hispanic or Latino 600 (95.5) 279 (95.2) 321 (95.8)
Missing e 2 0 2
Education
Did not finish high school 195 (31.0) 89 (30.4) 106 (31.5) 0.6612
Finished high school 255 (40.5) 124 (42.3) 131 (38.9)
Additional schooling beyond high school 180 (28.6) 80 (27.3) 100 (29.7)
Currently employed
Yes 105 (16.7) 52 (17.8) 53 (15.7) 0.4973
No 525 (83.3) 241 (82.3) 284 (84.3)
Currently experiencing homelessness
Yes 251 (39.8) 123 (42.0) 128 (38.0) 0.3067
No 379 (60.2) 170 (58.0) 209 (62.0)
Recruitment county
Rural g 135 (21.4) 58 (19.8) 77 (22.9) 0.3515
Urban h 495 (78.6) 235 (80.2) 260 (77.2)
Lifetime history of overdose
Yes 343 (54.5) 191 (65.4) 152 (45.1) < 0.0001 1.44 (1.20–1.74)
No 286 (45.5) 101 (34.6) 185 (54.9) Ref
Missing e 1 1 0
Overdose in the past six months (if lifetime = Yes)
Yes 113 (32.9) 56 (29.3) 57 (37.5) 0.1093
No 230 (67.1) 135 (70.7) 95 (62.5)
Worried about overdosing in future
Yes 306 (48.8) 152 (52.2) 154 (45.8) 0.1098
No 321 (51.2) 139 (47.8) 182 (54.2)
Missing e 3 2 1

Abbreviations: PR = Prevalence ratio; CI = Confidence interval; Ref = Reference

Bold indicates statistical significance

aRespondents were asked, “Before today, had you ever heard of xylazine being present in street drugs? (Xylazine is also known as tranq, tranq dope, Philly dope, sleep cut, or zombie drug.)” Missing responses were excluded from analyses

bP-values calculated from Chi-square, Fisher’s exact, or Wilcoxon-Mann-Whitney tests

cSignificant result from Chi-square test for drug overdose by xylazine awareness was examined further using Generalized Estimating Equations (GEE) estimation method for modified Poisson regression, controlling for age, sex, and race

dIncludes intersex, transgender female, & transgender male

eMissing values were omitted from the denominator when calculating percentages

fIncludes Asian, Native American, Indigenous, or Alaska Native, Native Hawaiian or Other Pacific Islander, Two or more races, and Other

gIncludes Guernsey, Knox, Logan, Marion, Muskingum, Ross, and Washington counties

hIncludes Butler, Cuyahoga, Franklin, Hamilton, Lucas, Mahoning, Miami, Montgomery, Portage, and Union counties